Next Article in Journal
Comparison of Efficacy in Patients with Metastatic Melanoma Treated with Ipilimumab and Nivolumab Who Did or Did Not Discontinue Treatment Due to Immune-Related Adverse Events: A Real-World Data Study
Next Article in Special Issue
3D Breast Tumor Models for Radiobiology Applications
Previous Article in Journal
First-Line Treatment of Metastatic Clear Cell Renal Cell Carcinoma: What Are the Most Appropriate Combination Therapies?
 
 
Article

Article Versions Notes

Cancers 2021, 13(21), 5549; https://doi.org/10.3390/cancers13215549
Action Date Notes Link
article xml file uploaded 5 November 2021 10:17 CET Original file -
article xml uploaded. 5 November 2021 10:17 CET Update -
article pdf uploaded. 5 November 2021 10:17 CET Version of Record -
article supplementary file uploaded. 5 November 2021 10:17 CET - https://www.mdpi.com/2072-6694/13/21/5549#supplementary
article html file updated 5 November 2021 10:18 CET Original file -
article xml file uploaded 5 November 2021 11:16 CET Update -
article xml uploaded. 5 November 2021 11:16 CET Update https://www.mdpi.com/2072-6694/13/21/5549/xml
article pdf uploaded. 5 November 2021 11:16 CET Updated version of record https://www.mdpi.com/2072-6694/13/21/5549/pdf
article html file updated 5 November 2021 11:18 CET Update -
article html file updated 30 July 2022 15:03 CEST Update https://www.mdpi.com/2072-6694/13/21/5549/html
Back to TopTop